Authors: Nole, F Munzone, E Mandala, M Catania, C Orlando, L Zampino, MG Minchella, I Colleoni, M Peruzzotti, G Marrocco, E Goldhirsch, A

Citation: F. Nole et al., Vinorelbine, cisplatin and continuous infusion of 5-fluorouracil (ViFuP) in metastatic breast cancer patients: A phase II study, ANN ONCOL, 12(1), 2001, pp. 95-100

Authors: Colleoni, M Minchella, I Mazzarol, G Nole, F Peruzzotti, G Rocca, A Viale, G Orlando, L Ferretti, G Curigliano, G Veronesi, P Intra, M Goldhirsch, A

Citation: M. Colleoni et al., Response to primary chemotherapy in breast cancer patients with tumors notexpressing estrogen and progesterone receptors, ANN ONCOL, 11(8), 2000, pp. 1057-1059

Authors: Colleoni, M Orvieto, E Nole, F Orlando, L Minchella, I Viale, G Peruzzotti, G Robertson, C Noberasco, C Galimberti, V Sacchini, V Veronesi, P Zurrida, S Orecchia, R Goldhirsch, A

Citation: M. Colleoni et al., Prediction of response to primary chemotherapy for operable breast cancer, EUR J CANC, 35(4), 1999, pp. 574-579

Authors: Nole, F Minchella, I Colleoni, M Orvieto, E Munzone, E de Braud, F Peruzzotti, G Martinelli, G Zampino, MG Catania, C Pizzamiglio, M Veronesi, P Zurrida, S Galimberti, V Goldhirsch, A Veronesi, U

Citation: F. Nole et al., Primary chemotherapy in operable breast cancer with favorable prognostic factors: A pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN), ANN ONCOL, 10(8), 1999, pp. 993-996